KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) EBITDA (2016 - 2026)

Clorox has reported EBITDA over the past 18 years, most recently at $466.0 million for Q1 2026.

  • For Q1 2026, EBITDA rose 143.98% year-over-year to $466.0 million; the TTM value through Mar 2026 reached $1.8 billion, up 71.54%, while the annual FY2025 figure was $2.0 billion, 12.14% up from the prior year.
  • EBITDA for Q1 2026 was $466.0 million at Clorox, up from $431.0 million in the prior quarter.
  • Over five years, EBITDA peaked at $596.0 million in Q2 2025 and troughed at -$207.0 million in Q1 2023.
  • A 5-year average of $251.6 million and a median of $207.0 million in 2022 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: soared 630.77% in 2022 and later crashed 200.0% in 2023.
  • Year by year, EBITDA stood at $115.0 million in 2022, then soared by 98.26% to $228.0 million in 2023, then plummeted by 30.26% to $159.0 million in 2024, then soared by 171.07% to $431.0 million in 2025, then grew by 8.12% to $466.0 million in 2026.
  • Business Quant data shows EBITDA for CLX at $466.0 million in Q1 2026, $431.0 million in Q4 2025, and $291.0 million in Q3 2025.